Signaturefd LLC Has $2.13 Million Holdings in Cigna Group (NYSE:CI)

Signaturefd LLC lifted its stake in shares of Cigna Group (NYSE:CI - Free Report) by 16.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,487 shares of the health services provider's stock after buying an additional 921 shares during the quarter. Signaturefd LLC's holdings in Cigna Group were worth $2,134,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. TCTC Holdings LLC purchased a new stake in Cigna Group in the 4th quarter valued at $25,000. Putney Financial Group LLC purchased a new stake in Cigna Group in the 4th quarter valued at $36,000. Transce3nd LLC purchased a new stake in Cigna Group in the 4th quarter valued at $38,000. Wayfinding Financial LLC purchased a new stake in Cigna Group in the 1st quarter valued at $40,000. Finally, Ameriflex Group Inc. purchased a new stake in Cigna Group in the 4th quarter valued at $44,000. Hedge funds and other institutional investors own 86.99% of the company's stock.

Cigna Group Stock Performance

Shares of CI traded down $7.54 during trading hours on Thursday, reaching $298.28. 1,696,422 shares of the company's stock traded hands, compared to its average volume of 1,738,626. The firm has a market capitalization of $79.68 billion, a price-to-earnings ratio of 16.52, a P/E/G ratio of 0.90 and a beta of 0.44. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.72 and a quick ratio of 0.72. Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83. The business's fifty day simple moving average is $315.21 and its two-hundred day simple moving average is $310.90.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, topping the consensus estimate of $6.35 by $0.39. Cigna Group had a net margin of 1.97% and a return on equity of 18.63%. The firm had revenue of $65.45 billion for the quarter, compared to analysts' expectations of $60.39 billion. During the same period in the previous year, the business earned $6.47 earnings per share. Cigna Group's revenue for the quarter was up 14.4% compared to the same quarter last year. Analysts predict that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 18th. Stockholders of record on Tuesday, June 3rd were issued a dividend of $1.51 per share. The ex-dividend date of this dividend was Tuesday, June 3rd. This represents a $6.04 annualized dividend and a dividend yield of 2.02%. Cigna Group's dividend payout ratio is 33.44%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on CI. Royal Bank Of Canada reissued an "outperform" rating and issued a $371.00 price objective on shares of Cigna Group in a research note on Thursday, June 26th. Mizuho upped their price target on shares of Cigna Group from $360.00 to $384.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Morgan Stanley upped their price target on shares of Cigna Group from $379.00 to $390.00 and gave the stock an "overweight" rating in a research note on Monday, May 5th. Cowen reaffirmed a "buy" rating on shares of Cigna Group in a research note on Monday, May 5th. Finally, Cantor Fitzgerald upped their price target on shares of Cigna Group from $350.00 to $365.00 and gave the stock an "overweight" rating in a research note on Thursday, March 20th. Two analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and three have given a strong buy rating to the company's stock. Based on data from MarketBeat, Cigna Group has an average rating of "Buy" and an average target price of $380.39.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.